ASH: Ibrutinib Bests Chlorambucil in Chronic Lymphocytic Leukemia
Improvements in progression-free survival, overall survival, response rate for ibrutinib
Etiology of Leukemia in Breast Cancer Survivors Explored
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
Antidepressants Don’t Adversely Affect Tamoxifen Efficacy
No greater risk of breast cancer recurrence seen
Metformin Linked to Beneficial Changes in Gut Bacteria
Drug tied to increased bacteria which produce health-promoting short-chain fatty acids
IV Bisphosphonate Tx Linked to Drop in Bone Turnover in DMD
Need for therapies with less bone turnover suppression in Duchenne muscular dystrophy
Testosterone Treatment Tied to Improved Insulin Sensitivity
Increased insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism
CDC: Too Few Taking Needed Cholesterol-Lowering Drugs
Only half who should are using medications to help prevent cardiovascular disease
Cardiovascular Trial Sponsorship Significantly Impacts Findings
Favorable outcomes seven times more likely in industry- versus NIH-sponsored trials
Addition of Immunosuppression No Benefit in IgA Nephropathy
No improvement in outcomes, more adverse effects for intensive supportive care + immunosuppression
Lixisenatide Doesn’t Affect Cardiovascular Risk in T2DM
Findings among patients with type 2 diabetes and recent acute coronary syndrome
